6 Results for "

spondyloarthritis

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "spondyloarthritis" in MCE Product Catalog:

Cat. No.: HY-P2358
CAS No.: 1001405-52-2
PSMα3 is an inhibitor of NF-κB p65 and p38 MAPK. PSMα3 forms membrane pores and binds to residues of human insulin B chain to inhibit insulin aggregation. PSMα3 forms α-type amyloid-like fibrils to exert cytotoxic effects, and acts as a functional amyloid virulence determinant of Staphylococcus aureus. PSMα3 is applicable to research related to spondyloarthritis, rheumatoid arthritis, insulin-derived amyloidosis, and Staphylococcus aureus infection .
loading...
    loading...
Cat. No.: HY-P990762
CAS No.: 2484772-72-5
Synonyms: BCD-180

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

Seniprutug (BCD-180) is a humanized monoclonal antibody targeting the TRBV9 fragment. Seniprutug induces antibody-dependent cell-mediated cytotoxicity to eliminate TRBV9 + T cells. Seniprutug is applicable to research related to active radiographic axial spondyloarthritis .
loading...
    loading...
Cat. No.: HY-P99515
CAS No.: 2382921-73-3
Synonyms: GR 1501

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Xeligekimab (GR 1501) is an anti-human interleukin 17A (IL-17A) humanized monoclonal antibody. Xeligekimab inhibits the pro-inflammatory cascade. Xeligekimab can be used for the research of inflammatory disease, such as radiographic axial spondyloarthritis .
loading...
    loading...
Cat. No.: HY-P2358A
Target:  

NF-κB p38 MAPK

Research Areas:  

Infection Inflammation/Immunology

PSMα3 TFA is an inhibitor of NF-κB p65 and p38 MAPK. PSMα3 TFA forms membrane pores and binds to residues of human insulin B chain to inhibit insulin aggregation. PSMα3 TFA forms α-type amyloid-like fibrils to exert cytotoxic effects, and acts as a functional amyloid virulence determinant of Staphylococcus aureus. PSMα3 TFA is applicable to research related to spondyloarthritis, rheumatoid arthritis, insulin-derived amyloidosis, and Staphylococcus aureus infection .
loading...
    loading...
Cat. No.: HY-P992062

Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology

Anti-Mouse CD80 Antibody (TKMG48) is an antibody that targets mouse CD80. By specifically binding to and disrupting the CD80:PD-L1 complex to release PD-L1, Anti-Mouse CD80 Antibody (TKMG48) functions as an indirect PD-1 agonist without blocking CD28 co-stimulation or CD80-CTLA4 binding. Anti-Mouse CD80 Antibody (TKMG48) inhibits T cell activation, reduces T cell effector functions and antigen-specific CD8 + T cell populations, and does not interfere with the differentiation, migration, antigen presentation or surface marker expression of dendritic cells. Anti-Mouse CD80 Antibody (TKMG48) significantly attenuates disease severity in mouse models of arthritis, spondyloarthritis, multiple sclerosis and Sjögren's syndrome, and its activity depends on the expression of PD-1 and PD-L1 .
loading...
    loading...
Cat. No.: HY-P11833
CAS No.: 3053447-54-1
Target:  

TNF Receptor NF-κB

Research Areas:  

Inflammation/Immunology

TNFR1-IN-1 is a selective TNFR1 inhibitor with a Kd of 0.1 nM for hTNFR1. TNFR1-IN-1 inhibits TNFα-induced NF-κB signaling, with an IC50 value of 1.2 nM. TNFR1-IN-1 can be used in research related to inflammatory and immune diseases .
loading...
    loading...